Eikanger M, Sane S, Schraufnagel K, Slunecka J, Potts R, Freeling J
Res Sq. 2024; .
PMID: 39502780
PMC: 11537347.
DOI: 10.21203/rs.3.rs-5199838/v1.
Tumen D, Heumann P, Huber J, Hahn N, Macek C, Ernst M
Cancers (Basel). 2024; 16(15).
PMID: 39123414
PMC: 11312265.
DOI: 10.3390/cancers16152686.
Cao R, Guo S, Min L, Li P
Oncol Rep. 2024; 51(2).
PMID: 38186315
PMC: 10807360.
DOI: 10.3892/or.2024.8696.
Belliveau N, Footer M, Akdoan E, van Loon A, Collins S, Theriot J
Nat Commun. 2023; 14(1):5770.
PMID: 37723145
PMC: 10507112.
DOI: 10.1038/s41467-023-41452-x.
Bloom G, Norambuena A
Cytoskeleton (Hoboken). 2023; 81(1):30-34.
PMID: 37638691
PMC: 10919542.
DOI: 10.1002/cm.21782.
Up-Regulation of microRNA-424 Causes an Imbalance in AKT Phosphorylation and Impairs Enteric Neural Crest Cell Migration in Hirschsprung Disease.
Xu Z, Yan Y, Gu B, Cai W, Wang Y
Int J Mol Sci. 2023; 24(7).
PMID: 37047673
PMC: 10094892.
DOI: 10.3390/ijms24076700.
Mechanosensitive mTORC2 independently coordinates leading and trailing edge polarity programs during neutrophil migration.
Saha S, Town J, Weiner O
Mol Biol Cell. 2023; 34(5):ar35.
PMID: 36857159
PMC: 10162419.
DOI: 10.1091/mbc.E22-05-0191.
Novel roles of mTORC2 in regulation of insulin secretion by actin filament remodeling.
Blandino-Rosano M, Scheys J, Werneck-de-Castro J, Louzada R, Almaca J, Leibowitz G
Am J Physiol Endocrinol Metab. 2022; 323(2):E133-E144.
PMID: 35723227
PMC: 9291412.
DOI: 10.1152/ajpendo.00076.2022.
Functional implications of neutrophil metabolism during ischemic tissue repair.
Piccolo E, Thorp E, Sumagin R
Curr Opin Pharmacol. 2022; 63:102191.
PMID: 35276496
PMC: 8995387.
DOI: 10.1016/j.coph.2022.102191.
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer.
Joechle K, Guenzle J, Hellerbrand C, Strnad P, Cramer T, Neumann U
World J Gastrointest Oncol. 2021; 13(11):1632-1647.
PMID: 34853640
PMC: 8603445.
DOI: 10.4251/wjgo.v13.i11.1632.
mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in Mutated Glioma.
Liu Y, Lu Y, Li A, Celiku O, Han S, Qian M
Cancers (Basel). 2020; 12(4).
PMID: 32224866
PMC: 7226122.
DOI: 10.3390/cancers12040787.
Microglial metabolic flexibility supports immune surveillance of the brain parenchyma.
Bernier L, York E, Kamyabi A, Choi H, Weilinger N, MacVicar B
Nat Commun. 2020; 11(1):1559.
PMID: 32214088
PMC: 7096448.
DOI: 10.1038/s41467-020-15267-z.
The p52 isoform of SHC1 is a key driver of breast cancer initiation.
Wright K, Miller B, El-Meanawy S, Tsaih S, Banerjee A, Geurts A
Breast Cancer Res. 2019; 21(1):74.
PMID: 31202267
PMC: 6570928.
DOI: 10.1186/s13058-019-1155-7.
[MicroRNA-152 and microRNA-448 inhibit proliferation of colorectal cancer cells by targeting Rictor].
Zhang J, Han Z, Dong L, Li Z, Li K, Shi M
Nan Fang Yi Ke Da Xue Xue Bao. 2019; 39(5):533-539.
PMID: 31140416
PMC: 6743937.
DOI: 10.12122/j.issn.1673-4254.2019.05.06.
mTOR Signalling in Head and Neck Cancer: Heads Up.
Tan F, Bai Y, Saintigny P, Darido C
Cells. 2019; 8(4).
PMID: 30970654
PMC: 6523933.
DOI: 10.3390/cells8040333.
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of -altered non-small cell lung cancer.
Ruder D, Papadimitrakopoulou V, Shien K, Behrens C, Kalhor N, Chen H
Oncotarget. 2018; 9(74):33995-34008.
PMID: 30338041
PMC: 6188056.
DOI: 10.18632/oncotarget.26129.
Overexpression of Rictor protein in colorectal cancer is correlated with tumor progression and prognosis.
Wang L, Qi J, Yu J, Chen H, Zou Z, Lin X
Oncol Lett. 2017; 14(5):6198-6202.
PMID: 29113267
PMC: 5661410.
DOI: 10.3892/ol.2017.6936.
Targeting mTORC2 component rictor inhibits cell proliferation and promotes apoptosis in gastric cancer.
Bian Y, Xu J, Zhao W, Zhang Z, Tu L, Cao H
Am J Transl Res. 2017; 9(9):4317-4330.
PMID: 28979705
PMC: 5622274.
Transcriptional regulation of endothelial cell behavior during sprouting angiogenesis.
Jeong H, Hernandez-Rodriguez B, Kim J, Kim K, Enriquez-Gasca R, Yoon J
Nat Commun. 2017; 8(1):726.
PMID: 28959057
PMC: 5620061.
DOI: 10.1038/s41467-017-00738-7.
Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Joly M, Williams M, Hicks D, Jones B, Sanchez V, Young C
Breast Cancer Res. 2017; 19(1):74.
PMID: 28666462
PMC: 5493112.
DOI: 10.1186/s13058-017-0868-8.